Global ETD Search

Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.

Results

Showing 1 to 5 of 5 for “"cangrelor"”.

  1. Downstream Cangrelor versus upstream ticagrelor in patients with St-Segment elevation myocardial infarction

    … l’assorbimento orale può essere ostacolato, il cangrelor per via endovenosa rappresenta un’alternativa. L’obiettivo di questo studio è stato confrontare il cangrelor somministrato dopo l’angiografia coronarica (ovvero, “downstream”) con il pretrattamento con ticagrelor (ovvero, “upstream”). …

    catania Repository record for Downstream Cangrelor versus upstream ticagrelor in patients with St-Segment elevation myocardial infarction (opens in a new tab)

  2. Investigating small-molecule inhibitors of platelet aggregation

    … to further understand the mechanism of action of cangrelor – the most recently approved, and only intravenously acting P2Y12 antagonist; and 2) to discover novel, competitively acting, non-nucleotide-based reversible inhibitor(s) of ADP-induced platelet aggregation. A plate-based aggregometry …

    cambridge Repository record for Investigating small-molecule inhibitors of platelet aggregation (opens in a new tab)

  3. The Molecular Mechanism of Platelet Activation in Inflammation

    … heparin, heparan sulfate (HS), aspirin, and cangrelor. Heparin and HS effectively neutralised histone activity in a dose-dependent manner, with heparin demonstrating nearly complete inhibition at 12.5 U/ml, while HS at 100 µg/ml entirely suppressed activation. Additionally, the antiplatelet …

    westminster Repository record for The Molecular Mechanism of Platelet Activation in Inflammation (opens in a new tab)

  4. Development and experimental validation of a novel arterial thrombosis-on-a-chip microfluidic device

    … events. To assess this approach, I tested cangrelor and aspirin using my device. I found the treatment to be effective when collagen alone was used as a trigger for thrombosis, but when tissue factor was also used, as would occur in vivo, treatment with cangrelor and aspirin was …

    cambridge Repository record for Development and experimental validation of a novel arterial thrombosis-on-a-chip microfluidic device (opens in a new tab)

  5. A Microfluidic Approach For Investigating Thrombosis And Hemostasis: From Disease Models To Drug Testing

    … results in a phase I clinical trial showed that cangrelor is an excellent candidate for preventing shunt thrombosis in neonatal patients after surgical operations. Using microfluidic devices, we demonstrated that thrombosis-and-hemostasis-on-a-chip could help us understand the mechanisms of …

    penn Repository record for A Microfluidic Approach For Investigating Thrombosis And Hemostasis: From Disease Models To Drug Testing (opens in a new tab)